Rhonda Farnum - 20 May 2022 Form 4 Insider Report for Theravance Biopharma, Inc. (TBPH)

Role
SVP, COMM & MEDICAL AFFAIRS
Signature
/s/ Brett A. Grimaud, Attorney-in-Fact
Issuer symbol
TBPH
Transactions as of
20 May 2022
Net transactions value
-$28,881
Form type
4
Filing time
24 May 2022, 19:11:35 UTC
Previous filing
02 Mar 2022
Next filing
23 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TBPH Ordinary Shares Tax liability $19,228 -2,200 -0.66% $8.74 331,071 20 May 2022 Direct F1
transaction TBPH Ordinary Shares Sale $9,653 -1,081 -0.33% $8.93 329,990 23 May 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.
F2 This transaction was executed in accordance with the reporting person's 10b5-1 plan dated 5/17/21.